106 related articles for article (PubMed ID: 10357388)
1. Cytotoxic T lymphocyte recognition of HLA-B*5101-restricted HIV-1 Rev epitope which is naturally processed in HIV-1-infected cells.
Tomiyama H; Chujoh Y; Shioda T; Miwa K; Oka S; Kaneko Y; Takiguchi M
AIDS; 1999 May; 13(7):861-3. PubMed ID: 10357388
[No Abstract] [Full Text] [Related]
2. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.
Van Baalen CA; Schutten M; Huisman RC; Boers PH; Gruters RA; Osterhaus AD
J Virol; 1998 Aug; 72(8):6851-7. PubMed ID: 9658134
[TBL] [Abstract][Full Text] [Related]
3. The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes.
Gruters RA; van Baalen CA; Osterhaus AD
Vaccine; 2002 May; 20(15):2011-5. PubMed ID: 11983265
[TBL] [Abstract][Full Text] [Related]
4. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
Blazevic V; Ranki A; Krohn KJ
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev.
Makadzange AT; Gillespie G; Kimani J; Kiama P; Easterbrook P; Bwayo JJ; Rowland-Jones SL
AIDS; 2006 Feb; 20(3):462-4. PubMed ID: 16439884
[TBL] [Abstract][Full Text] [Related]
7. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.
Addo MM; Altfeld M; Rosenberg ES; Eldridge RL; Philips MN; Habeeb K; Khatri A; Brander C; Robbins GK; Mazzara GP; Goulder PJ; Walker BD;
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1781-6. PubMed ID: 11172028
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
van Baalen CA; Pontesilli O; Huisman RC; Geretti AM; Klein MR; de Wolf F; Miedema F; Gruters RA; Osterhaus AD
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1913-8. PubMed ID: 9266987
[TBL] [Abstract][Full Text] [Related]
9. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.
Harrer EG; Bergmann S; Eismann K; Rittmaier M; Goldwich A; Müller SM; Spriewald BM; Harrer T
AIDS; 2005 Apr; 19(7):734-5. PubMed ID: 15821402
[TBL] [Abstract][Full Text] [Related]
10. Effective recognition of HIV-1-infected cells by HIV-1 integrase-specific HLA-B∗4002-restricted T cells.
Watanabe T; Murakoshi H; Gatanaga H; Koyanagi M; Oka S; Takiguchi M
Microbes Infect; 2011 Feb; 13(2):160-6. PubMed ID: 20971209
[TBL] [Abstract][Full Text] [Related]
11. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
14. HIV/AIDS. HLA leaves its footprints on HIV.
McMichael A; Klenerman P
Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
[No Abstract] [Full Text] [Related]
15. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel HLA-B-35-restricted cytotoxic T-lymphocyte epitope within human immunodeficiency type 1 (HIV-1) P17(Gag).
M'Bika JP; Achour A
Immunol Lett; 2002 Oct; 83(3):149-50. PubMed ID: 12095703
[No Abstract] [Full Text] [Related]
17. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
19. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
20. HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.
Kløverpris HN; Stryhn A; Harndahl M; Payne R; Towers GJ; Chen F; Riddell L; Walker BD; Ndung'u T; Leslie A; Buus S; Goulder P
J Virol; 2013 Oct; 87(19):10889-94. PubMed ID: 23864640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
